Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,464 signal articles · 148 in last 24h · 154,187 total before filter · latest 1h ago
148last 24h
870last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro209Earnings107M&A125Regulatory21Product21Analyst18
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
China launches year-long auto quality drive, mandates defect recalls
Reuters28d agobearish
China launches year-long auto quality drive, mandates defect recalls

BEIJING, Aug 27 () - Chinese regulators on Thursday ordered automakers to file proactive recall plans for any defects uncovered in self-audits, ‌as part of a year-long campaign to improve vehicle quality ‌and safety in the world's largest auto market. Tesla and eight Chinese electric vehicle makers ​on August 21 announced fixes affecting a combined 4.

Youth Engagement Lawsuit Could Be A Game Changer For Snap’s (SNAP) Core Monetization Model
Simply Wall St.29d agobearish
Youth Engagement Lawsuit Could Be A Game Changer For Snap’s (SNAP) Core Monetization Model

Pennsylvania’s Attorney General has sued Snap Inc., alleging that Snapchat misleads parents about mature content and uses design features that encourage compulsive use among minors, and is seeking civil penalties and changes to how the platform is marketed and accessed. Beyond the legal exposure, the case goes to the heart of Snap’s engagement model by questioning features like Snapstreaks, infinite scroll and Friend Solar System that help shape user behavior, especially for younger...

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga29d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization

What Could JPMorgan Chase (JPM) Lawsuits Mean For Future M And A Deals?
Simply Wall St.31d agobearish
What Could JPMorgan Chase (JPM) Lawsuits Mean For Future M And A Deals?

JPMorgan Chase (NYSE:JPM) and Morgan Stanley are facing ongoing shareholder lawsuits tied to recent multibillion dollar buyout deals that took public companies private. The complaints allege the banks facilitated undervalued sales to private equity buyers and breached fiduciary duties in their advisory roles. These cases are testing the scope of legal protections for large banks involved in M&A transactions under evolving corporate law. Investors are watching the proceedings for potential...

What Is Intuit (INTU) Facing In This New Investor Lawsuit?
Simply Wall St.31d agobearish
What Is Intuit (INTU) Facing In This New Investor Lawsuit?

Intuit (NasdaqGS: INTU) and several top executives face a new class action lawsuit alleging they misled investors about generative AI competition and Mailchimp performance. The complaint claims Intuit understated the competitive threat from generative AI tools and misrepresented trends in Mailchimp's business. Plaintiffs have expanded the suit to cover a longer class period, building on earlier litigation focused on similar issues. The case raises fresh questions about Intuit's disclosures...

Tesla (TSLA) Is Recalling Nearly 3 Million Vehicles In China
Simply Wall St.33d agobearish
Tesla (TSLA) Is Recalling Nearly 3 Million Vehicles In China

Tesla (NasdaqGS:TSLA) is recalling nearly 3 million vehicles in China due to potential safety issues with emergency door releases. The recall is the company’s largest in China to date and affects vehicles already on Chinese roads. Separately, Tesla has introduced a new Powerwall home battery leasing plan as competition in residential energy storage increases. The recall and the Powerwall shift could influence how regulators, consumers and investors view Tesla’s broader business model. This...

Is AST SpaceMobile (ASTS) At Risk From A $15 Million Fee Lawsuit?
Simply Wall St.35d agobearish
Is AST SpaceMobile (ASTS) At Risk From A $15 Million Fee Lawsuit?

AST SpaceMobile (NasdaqGS:ASTS) has been sued by Delclaux Partners over more than US$15 million in disputed contractual finder’s fees. The lawsuit centers on alleged unpaid compensation linked to financing arrangements that Delclaux Partners claims it helped source. The case raises questions about AST SpaceMobile’s contractual obligations and potential financial and reputational risks. This kind of legal and financing friction is not unique to AST SpaceMobile. It can be useful to compare...

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy
Simply Wall St.35d agoneutral
Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron’s portfolio, reinforcing the company’s focus on specialized, high-complexity immunology therapies. We’ll now examine how Pasatru’s FOP approval, as an ultra-rare...